Impact of Serum Pro-calcitonin Level Among SARS-CoV-2 Infected Patients: Emphasizing on A Medullary Thyroid Cancer Survivor in Kolkata, India

• Published in: SVOA Microbiology Vol. 4; no. 2; pp. 42 - 47
• Main Authors: Chatterjee, Rajendra Prasad, Chatterjee, Shilpa, Sikdar, Subhendu, Chowdhury, Aparna, Bhattacharjee, Debolina, Majumder, Titlee, Mitra, Nilanjana, Pramanik, Bithika, Das, Biswajit, Ghosh, Reena Ray
• Format: Journal Article
• Language: English
• Published: 14.08.2023
• ISSN: 2634-534X; 2634-534X
• DOI: 10.58624/SVOAMB.2023.04.030

The coronavirus that causes severe acute respiratory syndrome (SARS-CoV-2) is a positive sense single stranded RNA (ssRNA) virus that first appeared in China and has spread throughout the world since late 2019. The SARS-CoV-2 virus causes a mild to severe respiratory infection that affects not just the lungs but also pancreas and other endocrine glands, as well as responsible for ischemic stroke and sexual dysfunctions. Serum pro-calcitonin (PCT) levels have been linked to the severity of coronavirus disease (COVID-19) in several investigations. According to our studies, high PCT levels are linked to a greater risk of severe COVID-19 infection in patients, as well as its involvement and role in a COVID-19 infected cancer survivor. This is the first study we are aware of from India that shows COVID-19 infected people should have regular PCT screening may help clinicians to plan intensive care unit (ICU) placement and detect any recurrence of past illness if any.